Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

1.540 +0.020 (+1.32%)
Official Closing Price Updated: 8:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues
Via Investor Brand Network
Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy
Via Investor Brand Network
Researchers Urge Canadians to Donate Toenails, for Science
Via Investor Brand Network
Researchers Discover Why Cancer Immunotherapy Could Be Failing
Via Investor Brand Network
Lund University Researchers Discover Why Leukemia Cells Evade the Immune System
Via Investor Brand Network
Researchers Find That Common Nutrient Could Supercharge the Immune Cells Fighting Cancer
Via Investor Brand Network
How Patients Can Boost Dietary Nutrient Intake During Cancer Treatment
Via Investor Brand Network
Study Finds That Common Sweetener Could Compromise Cancer Treatment Effectiveness
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Present at H.C. Wainwright Global Investment Conference
Via Investor Brand Network
New Study Discovers Unexpected Reason for Resistance to Cancer Immunotherapy
Via Investor Brand Network
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option
Via Investor Brand Network
Scientists Turn Bacteria into Trojan Horses to Deliver Anti-Cancer Viruses into Tumors
Via Investor Brand Network
Which stocks are experiencing notable movement on Wednesday?
Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Nasdaq Down 1%; Lowe's Posts Upbeat Earnings
 
Via Benzinga
Let's take a look at the stocks that are in motion in today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Prices $6 Million Public Offering
Via Investor Brand Network
Traders are paying attention to the gapping stocks in Wednesday's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday. 
Via Chartmill
Dow Surges 100 Points; Target Shares Fall After Q2 Results
 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
What's going on in today's session
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
Monday's session: top gainers and losers
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Q2 2025 Results and Business Highlights
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Calidi Loss Down 23 Percent in Fiscal Q2
Via The Motley Fool
Topics Intellectual Property
Breakthrough Treatment for Lung Cancer Uses Mitochondria to Supercharge Immune Cells
Via Investor Brand Network
New Genetic Discovery Could Boost Cancer Immunotherapy
Via Investor Brand Network
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.